￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Medical drugs

Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Reasons and policy analysis on why Trelagliptin is not yet sold in the domestic market

2026-02-01 22:25:32

Check Details
Analysis of one-month treatment cost and medical insurance reimbursement of inavolisib

2026-02-01 22:25:32

Check Details
A comprehensive introduction to Abatacept’s latest price trends and buying advice

2026-02-01 22:25:32

Check Details
Analysis of the price trend and medical insurance situation of Almonertinib as a targeted drug

2026-02-01 22:25:32

Check Details
Whether Lebrasin (Daveco) has been included in medical insurance and the actual price after medical insurance reimbursement

2026-02-01 22:25:32

Check Details
Analysis of the main functions, mechanism of action and indications of Mavakaita (Maifantuo) capsules

2026-02-01 22:25:32

Check Details
Analysis of the differences between domestic and imported versions of tenofovir alafenamide fumarate tablets (Vemlidy)

2026-02-01 22:25:32

Check Details
Vorasidenib-VORANIGO is suitable for people and situations in which its use is not recommended

2026-02-01 22:25:32

Check Details
Interactions and risks of eflornithine (IWILFIN) with other drugs

2026-02-01 22:25:32

Check Details
Applicable population range of Odesibat (Belvi) and medication recommendations for different patients

2026-02-01 22:25:32

Check Details
Reasons for mental state decline after taking donepezil (Aricept) for 20 days

2026-02-01 22:25:32

Check Details
Fidaxomicin’s domestic marketing progress and interpretation of relevant approval information

2026-02-01 22:25:32

Check Details
Category
相关知识